July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
July 30, 2022 at 09:01 AM EDT
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more.
